InvisiDerm Healthcare

InvisiDerm is a medical technology company specializing in the development of non-invasive, active transdermal drug delivery systems. The company's proprietary platform is designed to facilitate the delivery of large molecule therapeutics, including biologics and vaccines, which typically require needle-based administration. By utilizing a controlled, active transport mechanism, InvisiDerm aims to provide a painless and more convenient alternative to injections, potentially improving patient adherence in chronic disease management. The technology has applications across various therapeutic areas, including metabolic disorders, pain management, and dermatology. InvisiDerm's approach focuses on enhancing the permeability of the skin to allow for the efficient systemic or local absorption of drugs. The company is currently advancing its platform through pre-clinical studies with a focus on high-impact indications such as diabetes and immunization.